Diffuse Large B-Cell Lymphoma Market - Witness Global Need 2025 : Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd.
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non hodgkin lymphoma (NHL) and is the main reason behind more than 30% of the newly diagnosed cancer cases in the U.S. alone.
View full press release